Drugs / DV-10
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07544589 | Apr 2026 → Apr 2046 expected | colorectal cancer, esophageal adenocarcinoma, gastric adenocarcinoma, gastroesophageal adenocarcinoma | Dispatch Biotherapeutics | Recruiting | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DV-10 | “DV-10 (adenovirus)” NCT07544589 ↗ |